Research

Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus.

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths.

Interventions for delirium in the emergency department setting are needed to preserve patients’ long-term function and cognition, Vanderbilt investigators have found.

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

Researchers at Vanderbilt University Medical Center (VUMC) have mapped the conformational changes that occur in a protein “notorious” for pumping chemotherapeutic drugs out of cancer cells and blocking medications from reaching the central nervous system.

Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).

Treatment in the Neonatal Intensive Care Unit (NICU) saves millions of infants born prematurely every year. But treatment is not without cost. Painful procedures such as needle pricks can impact early brain development.